Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Eylea“
Suchtreffer
Begriffe & Kennungen
Eylea · 4.5 · No interaction studies have been performed.
Eintrag öffnenEylea · 4.5 · Paediatric population No interaction studies have been performed.
Eintrag öffnenEylea · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenEylea · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenEylea · 4.6 Fertility, pregnancy and lactation · 3
Eintrag öffnenEylea · 4.8 Undesirable effects · 1
Eintrag öffnenEylea · 4.8 Undesirable effects · 2
Eintrag öffnenEylea · 4.8 Undesirable effects · 3
Eintrag öffnenEylea · 4.8 · 39 Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (1/10,000 to <1/1,000),
Eintrag öffnenEylea · 4.8 · 40 Reporting of suspected adverse reactions
Eintrag öffnenEylea · 4.8 · 69 Table 1: All treatment-emergent adverse reactions reported in patients with nAMD, DME or RVO treated with E
Eintrag öffnenEylea · 4.8 · 8 Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (1/10,000 to <1/1,000),
Eintrag öffnenEylea · 4.8 · 9 Paediatric population The safety of Eylea for the treatment of ROP was evaluated in a 6-month phase III stud
Eintrag öffnenEylea · 4.8 · A total of 1 808 patients treated with Eylea 114.3 mg/ml up to 96 weeks constituted the safety population in 4
Eintrag öffnenEylea · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnenEylea · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnenEylea · 4.8 · Adverse reactions established for adult indications are considered applicable to preterm infants with ROP, tho
Eintrag öffnenEylea · 4.8 · Adverse reactions reported in more than one patient treated with aflibercept 0.4 mg were retinal detachment, r
Eintrag öffnenEylea · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenEylea · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnen